| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2021 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 30,000 | $285.02 | $8,550,556.50 | -1.4% | |
| Feb 11, 2021 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 292,773 | $165.55 | $48,469,474.36 | -0.8% | |
| Feb 11, 2021 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 6,613 | $168.46 | $1,114,041.56 | -0.7% | |
| Feb 10, 2021 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Chairman Of The Bd. | Sell | 1,000 | $1,220.00 | $1,220,000.00 | -13.7% | |
| Feb 10, 2021 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 4,934 | $162.71 | $802,811.14 | -54.9% | |
| Feb 10, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 14,375 | $94.47 | $1,358,038.84 | -0.1% | |
| Feb 10, 2021 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | CFO &COO, Lab Operations | Sell | 4,000 | $160.00 | $640,000.00 | -38.5% | |
| Feb 10, 2021 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 15,000 | $95.35 | $1,430,253.15 | -0.3% | |
| Feb 9, 2021 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Sell | 10,000 | $155.48 | $1,554,800.00 | -41.9% | |
| Feb 9, 2021 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | President And CEO | Sell | 5,000 | $1,211.41 | $6,057,027.40 | -2.6% | |
| Feb 9, 2021 | WAT Waters Corp /de/ | Reed Joann A47 | Director | Sell | 4,759 | $282.39 | $1,343,908.92 | -4.1% | |
| Feb 9, 2021 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 1,000 | $1,212.14 | $1,212,140.00 | -89.0% | |
| Feb 9, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 28,750 | $95.21 | $2,737,165.56 | -0.3% | |
| Feb 9, 2021 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 454,650 | $162.21 | $73,747,591.04 | -1.2% | |
| Feb 8, 2021 | MTD Mettler Toledo International Inc/ | Aggersbjerg Peter54 | Head Of Divisions &Operations | Sell | 600 | $1,197.52 | $718,512.00 | -85.2% | |
| Feb 8, 2021 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Chairman Of The Bd. | Sell | 1,000 | $1,200.00 | $1,200,000.00 | -13.7% | |
| Feb 8, 2021 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 1,287 | $1,194.00 | $1,536,678.00 | -20.8% | |
| Feb 8, 2021 | MTD Mettler Toledo International Inc/ | Salice Thomas P65 | Director | Sell | 1,484 | $1,193.00 | $1,770,412.00 | -3.3% | |
| Feb 5, 2021 | IMDX Insight Molecular Diagnostics Inc. | Broadwood Partners, L.P.60 | 10% Owner | Buy | 600,000 | $4.50 | $2,700,000.00 | +1.8% | |
| Feb 5, 2021 | XGN Exagen Inc. | Tullis James L L73 | Director, 10% Owner | Sell | 3,000 | $17.00 | $51,000.00 | -12.3% | |
| Feb 5, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 10,000 | $89.82 | $898,190.35 | -0.6% | |
| Feb 4, 2021 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 142,400 | $158.73 | $22,603,341.19 | -0.5% | |
| Feb 2, 2021 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 63,190 | $122.57 | $7,745,186.91 | -8.6% | |
| Feb 2, 2021 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 260,404 | $156.58 | $40,773,636.81 | -0.7% | |
| Feb 1, 2021 | RVTY Revvity, Inc. | Tereau Daniel R69 | Please See Remarks | Sell | 2,047 | $147.07 | $301,052.29 | -18.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.